Ontogeny of epidermal growth factor receptor and lipocortin-1 in fetal and neonatal human lungs.
The ontogeny and distribution of the epidermal growth factor (EGF) receptor and lipocortin-1, a major cellular substrate of the EGF receptor, were evaluated in a developmental series of fetal and neonatal human lungs (8 to 41 weeks' gestation and stillborn to 16 days' postnatal age). The peroxidase anti-peroxidase technique with two polyclonal antibodies recognizing the EGF receptor and one polyclonal antibody recognizing lipocortin-1 were used for immunohistochemical localization. Extensive or scattered bronchiolar EGF receptor immunoreactivity appeared in the entire series of frozen lung specimens from 15 to 32 weeks' gestation. Bronchial glands exhibited EGF receptor immunostaining from 19 weeks onward, and immunoreactivity in bronchial epithelium was detected from 23 weeks onward. Most tracheas showed extensive lipocortin-1 immunoreactivity in the epithelium beginning at 10 weeks' gestation. Immunostaining was also seen in cells lining the ducts of submucosal glands after 15 weeks' gestation and in nonmucous acinar cells of tracheal glands after their appearance at 18 weeks' gestation. Bronchial epithelium exhibited lipocortin-1 immunoreactivity from 12 weeks' gestation onward. Bronchial gland necks became immunostained from 16 weeks' gestation onward, followed by acinar immunostaining as they subsequently developed. Bronchiolar epithelium was immunostained as early as 12 weeks, beginning with the largest airways, and by 24 weeks extending distally to the bronchioloalveolar portals. Lipocortin-1 immunostaining of larger conducting airway epithelium was primarily confined to ciliated cells. Neither EGF receptor nor lipocortin-1 immunoreactivity was detected in alveolar type I or type II cells, fibrocytes, chondrocytes, or smooth muscle cells at any gestational age. These developmental patterns suggest that the EGF receptor and lipocortin-1 may participate in normal growth factor-induced proliferation of the conducting airways and their glands in the human fetal lung and trachea.
Johnson
M D
MD
Department of Pathology, Vanderbilt University, School of Medicine, Nashville, TN 37232-2370.
Gray
M E
ME
Carpenter
G
G
Pepinsky
R B
RB
Stahlman
M T
MT
D017302:Annexins; D002135:Calcium-Binding Proteins / Q000032:analysis*; D066246:ErbB Receptors / Q000032:analysis*; D005260:Female; D005333:Fetus / Q000032:analysis* / Q000166:cytology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007231:Infant, Newborn; D008168:Lung / Q000032:analysis* / Q000166:cytology / Q000473:pathology; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D011247:Pregnancy; D014132:Trachea / Q000032:analysis / Q000166:cytology / Q000473:pathology
D017302:Annexins; D002135:Calcium-Binding Proteins; D066246:ErbB Receptors; D010740:Phospholipases